Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Post COVID: Sites Evolving Role in the Clinical Trial Ecosystem
Session Chair(s)
Cristin MacDonald, PhD
- Vice President, Client Delivery
- WCG Avoca, United States
Following COVID-19, there is a changing role for Sites in the decision-making framework for the selection, implementation, and use of various technologies for clinical trial execution. We will discuss how Sponsors, CROs and Sites can move forward.
Learning Objective : Review the rapid response working group findings as it related to site execution and monitoring during the COVID-pandemic; Discuss how COVID-19 impacted traditional clinical trial execution decision making from dictating to sites how to conduct the research, to including/listening to sites for appropriate next steps; Identify how technology adoption in clinical trial execution will be decided upon.
Speaker(s)
Panelist
Greg Tuyteleers
- Global Operations Head Managed Access and Global Lead Decentralized Trials
- Janssen, Belgium

Panelist
Liz Rogers, MSc
- Vice President, Head of Global Site and Study Operations
- Pfizer Inc, United States
Panelist
Andy Lee, MA
- Senior Vice President, Head of Global Clinical Trial Operations
- Merck & Co., Inc., United States

Panelist
Sandy Smith
- SVP Clinical Solutions and Strategic Partnerships
- WCG Cinical, United States